Boston Scientific Corporation
BSX
Rank in Stocks
#409
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
Share Price
$41.88
Last synced: 2026-10-30
Market Cap
$60.69B
Change (1 day)
-1.89%
Change (1 year)
-58.42%
Country
US
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Boston Scientific Corporation (BSX)
Category
Healthcare
Number of shares outstanding for Boston Scientific Corporation (BSX)
Number of shares outstanding as of September 2026: 1.45B
According to Boston Scientific Corporation's latest financial reports, its current number of shares outstanding is 1.45B. At the end of 2025 the company had 1.48B shares outstanding. The number of shares outstanding usually changes with stock splits and share buybacks.
Shares outstanding history for Boston Scientific Corporation (BSX) from 2000 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 1.45B | -2.14% |
| 2025 | 1.48B | 0.60% |
| 2024 | 1.47B | 1.27% |
| 2023 | 1.45B | 1.57% |
| 2022 | 1.43B | 0.58% |
| 2021 | 1.42B | 0.40% |
| 2020 | 1.42B | 1.81% |
| 2019 | 1.39B | 0.76% |
| 2018 | 1.38B | 0.80% |
| 2017 | 1.37B | 0.92% |
| 2016 | 1.36B | 2.25% |
| 2015 | 1.33B | 0.26% |
| 2014 | 1.32B | -1.26% |
| 2013 | 1.34B | -4.66% |
| 2012 | 1.41B | -6.80% |
| 2011 | 1.51B | -0.56% |
| 2010 | 1.52B | 0.66% |
| 2009 | 1.51B | 0.63% |
| 2008 | 1.50B | 0.78% |
| 2007 | 1.49B | 16.74% |
| 2006 | 1.27B | 54.14% |
| 2005 | 826.32M | -1.18% |
| 2004 | 836.22M | 0.98% |
| 2003 | 828.07M | 2.12% |
| 2002 | 810.87M | -2.40% |
| 2001 | 830.77M | 2.45% |
| 2000 | 810.87M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 1.74B | 19.98% |
US
|
|
| 1.28B | -11.66% |
IE
|
|
| 383.50M | -73.53% |
US
|
|
| 1.12B | -22.74% |
DE
|
|
| 576.40M | -60.21% |
US
|
Questions about Boston Scientific Corporation's number of shares outstanding
What is Boston Scientific Corporation's number of shares outstanding?
Boston Scientific Corporation's number of shares outstanding is 1.45B, as of Sep 2026.
What was Boston Scientific Corporation's number of shares outstanding in 2025?
In 2025, Boston Scientific Corporation's number of shares outstanding was 1.48B, 0.60% more than in 2024 (1.47B).
How has Boston Scientific Corporation's number of shares outstanding changed since 2020?
From 2020 to 2025, Boston Scientific Corporation's number of shares outstanding went from 1.42B to 1.48B, an average growth of 0.88% a year.